DA
DCF Advisers’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Hold |
10,750
| – | – | 0.92% | 37 |
|
|
2025
Q1 | $2.25M | Sell |
10,750
-20,750
| -66% | -$4.35M | 1.08% | 30 |
|
|
2024
Q4 | $5.6M | Buy |
31,500
+500
| +2% | +$88.9K | 2.71% | 10 |
|
|
2024
Q3 | $6.12M | Sell |
31,000
-800
| -3% | -$158K | 2.45% | 9 |
|
|
2024
Q2 | $5.45M | Hold |
31,800
| – | – | 2.81% | 8 |
|
|
2024
Q1 | $5.79M | Sell |
31,800
-700
| -2% | -$127K | 2.85% | 7 |
|
|
2023
Q4 | $5.04M | Sell |
32,500
-12,000
| -27% | -$1.86M | 2.73% | 7 |
|
|
2023
Q3 | $6.63M | Sell |
44,500
-3,050
| -6% | -$455K | 3.61% | 5 |
|
|
2023
Q2 | $6.41M | Sell |
47,550
-24,450
| -34% | -$3.29M | 3.38% | 6 |
|
|
2023
Q1 | $11.5M | Hold |
72,000
| – | – | 7.02% | 1 |
|
|
2022
Q4 | $11.6M | Sell |
72,000
-4,100
| -5% | -$663K | 7.86% | 1 |
|
|
2022
Q3 | $10.2M | Buy |
76,100
+1,000
| +1% | +$134K | 6.6% | 1 |
|
|
2022
Q2 | $11.5M | Sell |
75,100
-13,650
| -15% | -$2.09M | 6.85% | 2 |
|
|
2022
Q1 | $14.4M | Sell |
88,750
-10,568
| -11% | -$1.71M | 6.3% | 2 |
|
|
2021
Q4 | $13.4M | Buy |
99,318
+21,568
| +28% | +$2.92M | 5.45% | 3 |
|
|
2021
Q3 | $8.39M | Buy |
77,750
+750
| +1% | +$80.9K | 3.7% | 5 |
|
|
2021
Q2 | $8.67M | Sell |
77,000
-25,000
| -25% | -$2.82M | 3.07% | 4 |
|
|
2021
Q1 | $11M | Buy |
102,000
+21,000
| +26% | +$2.27M | 4.8% | 4 |
|
|
2020
Q4 | $8.68M | Buy |
81,000
+17,000
| +27% | +$1.82M | 3.58% | 6 |
|
|
2020
Q3 | $5.61M | Buy |
64,000
+4,850
| +8% | +$425K | 2.87% | 8 |
|
|
2020
Q2 | $5.81M | Sell |
59,150
-6,000
| -9% | -$589K | 3.25% | 8 |
|
|
2020
Q1 | $4.96M | Buy |
65,150
+6,550
| +11% | +$499K | 3.25% | 6 |
|
|
2019
Q4 | $5.19M | Buy |
+58,600
| New | +$5.19M | 3.29% | 8 |
|